Conversely, NAFLD-HCC subjects had a lower percentage of CD8+ T cells (CD3+ CD8+) compared to NAFLD-cirrhosis and non-NAFLD controls (P = 0.017) (Fig. 1). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.